PUBLISHER: The Business Research Company | PRODUCT CODE: 1942577
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942577
A clot management device is a medical instrument crafted to prevent, manage, or eliminate blood clots within the vascular system. These devices are instrumental in treating blood clots, particularly concerning vascular conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
The primary product categories within the clot management devices market include neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF). Neurovascular embolectomy devices are specialized tools employed to extract clots from blood vessels in the brain. Percutaneous thrombectomy devices encompass various types such as aspiration thrombectomy devices and percutaneous mechanical thrombectomy devices, catering to end-users such as diagnostic centers and hospitals.
Tariffs are impacting the clot management devices market by increasing costs for imported catheters, guidewires, filters, and precision-engineered components used in thrombectomy and embolectomy devices. These cost pressures have particularly affected percutaneous thrombectomy and neurovascular embolectomy segments, with north america and asia-pacific regions experiencing higher exposure due to global supply chains. Increased tariffs have raised procurement costs for hospitals and diagnostic centers and influenced purchasing decisions. However, tariffs have also encouraged domestic manufacturing, supplier diversification, and regional production expansion, supporting long-term supply chain resilience.
The clot management devices market research report is one of a series of new reports from The Business Research Company that provides clot management devices market statistics, including clot management devices industry global market size, regional shares, competitors with a clot management devices market share, detailed clot management devices market segments, market trends and opportunities, and any further data you may need to thrive in the clot management devices industry. This clot management devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The clot management devices market size has grown strongly in recent years. It will grow from $1.82 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rising incidence of deep vein thrombosis and pulmonary embolism, increasing prevalence of cardiovascular diseases, growth in interventional radiology procedures, expanding hospital vascular care capabilities, improved awareness of clot-related complications.
The clot management devices market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to aging population with higher thrombotic risk, rising demand for minimally invasive vascular interventions, increasing focus on early diagnosis and treatment of clotting disorders, expansion of advanced stroke and thrombosis centers, growing adoption of endovascular treatment approaches. Major trends in the forecast period include rising adoption of minimally invasive clot removal procedures, increasing use of mechanical and aspiration thrombectomy devices, growing focus on rapid intervention for acute thrombotic events, expansion of catheter-based treatments for dvt and pe, increasing preference for retrievable inferior vena cava filters.
The projected increase in demand for hospitals is set to drive the growth of the clot management device market in the foreseeable future. Hospitals, specialized healthcare facilities catering to medical treatment, care, and services for individuals with diverse illnesses, injuries, or medical conditions, are on the rise due to several factors such as aging populations, urbanization, improved healthcare access, population growth, and medical tourism. Clot management devices play a pivotal role in the healthcare sector, serving as essential tools for treating conditions such as deep vein thrombosis, pulmonary embolism, and ischemic strokes. These devices offer patients effective and minimally invasive solutions, thereby enhancing overall treatment outcomes and ensuring patient safety. For example, data from the American Health Care Association reveals an increase in the number of hospitals in the US from 5,129 in 2022 to 6,120 in May 2024. Consequently, the growing demand for hospitals is fueling the expansion of the clot management device market.
Key players in the clot management device market are focusing on developing innovative technologies, such as computer-assisted vacuum thrombectomy (CAVT) systems, to meet the evolving needs of customers. Computer-assisted vacuum thrombectomy (CAVT) systems are medical devices utilized in treating blood clots, particularly in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). For instance, in April 2024, Penumbra Inc., a US-based medical company, introduced the Lightning Flash 2.0, the latest clot aspiration and vacuum thrombectomy technology. This cutting-edge device offers rapid blood clot removal, representing a significant advancement in clot management devices. The Lightning Flash 2.0 integrates advanced artificial intelligence and sophisticated engineering to enhance patient outcomes in both acute and chronic care settings. Equipped with advanced imaging and suction capabilities, it enables precise and efficient clot removal to address various medical scenarios.
In December 2023, Johnson & Johnson (J&J) MedTech, a US-based healthcare company, acquired Laminar Ltd. for $400 million. This acquisition is aimed at strengthening J&J MedTech's position in the clot management devices market by incorporating Laminar's innovative left atrial appendage (LAA) closure technology. This technology helps reduce the risk of stroke in atrial fibrillation patients who are unable to take long-term blood thinners, thereby enhancing J&J's cardiovascular product portfolio and advancing stroke prevention solutions. Laminar Inc., a US-based medical device company, specializes in developing clot management devices and heart implants to reduce stroke risk.
Major companies operating in the clot management devices market are Bayer AG, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Acandis GmbH & Co KG, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Inari Medical Inc., AngioDynamics Inc., Argon Medical Devices Inc., LeMaitre Vascular Inc., iVascular SLU, Straub Medical AG, Rapid Medical, C.R. Bard Inc., InspireMD Inc.
North America was the largest region in the clot management devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clot management devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the clot management devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The clot management devices market consists of sales of catheter-directed thrombolysis systems, thrombectomy devices, and inferior vena cava (IVC) filters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clot Management Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses clot management devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for clot management devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clot management devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.